CVS
CVS Health Corp
NYSE: CVS · HEALTHCARE · HEALTHCARE PLANS
$92.22
+1.17% today
Updated 2026-06-05
Market cap
$114.20B
P/E ratio
39.25
P/S ratio
0.28x
EPS (TTM)
$2.28
Dividend yield
2.94%
52W range
$57 – $98
Volume
8.0M
CVS Health Corp (CVS) Insider transactions
Net insider activity
Net selling (6,314,102 shares)
Buy transactions
63
Sell transactions
37
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-31 | NEWMAN, BRIAN | EVP, Chief Financial Officer | Sale | 2,478 | $90.98 | $225448.44 |
| 2026-05-31 | COMPTON-PHILLIPS, AMY | EVP, Chief Medical Officer | Sale | 7,618 | $90.98 | $693085.64 |
| 2026-05-21 | ROBBINS, LARRY | Director | Sale | 370,462 | $93.45 | $34.62M |
| 2026-05-21 | ROBBINS, LARRY | Director | Sale | 378,000 | $93.31 | $35.27M |
| 2026-05-21 | AGUIRRE, FERNANDO | Director | Sale | 1,563 | $93.50 | $146142.06 |
| 2026-05-20 | ROBBINS, LARRY | Director | Sale | 797,628 | $93.48 | $74.56M |
| 2026-05-20 | ROBBINS, LARRY | Director | Sale | 152,691 | $94.81 | $14.48M |
| 2026-05-20 | ROBBINS, LARRY | Director | Sale | 66,881 | $95.67 | $6.40M |
| 2026-05-20 | ROBBINS, LARRY | Director | Sale | 800 | $96.28 | $77025.52 |
| 2026-05-20 | AGUIRRE, FERNANDO | Director | Sale | 30,437 | $93.78 | $2.85M |
| 2026-05-19 | ROBBINS, LARRY | Director | Sale | 1,983,387 | $94.45 | $187.33M |
| 2026-05-19 | ROBBINS, LARRY | Director | Sale | 151 | $95.18 | $14372.18 |
| 2026-05-14 | SHULMAN, DOUGLAS H. | Director | Buy | 1,448 | $97.15 | $140673.20 |
| 2026-05-14 | SANSONE, GUY P | Director | Buy | 1,447 | $97.15 | $140576.05 |
| 2026-05-14 | ROBBINS, LARRY | Director | Buy | 1,930 | $97.15 | $187499.50 |
| 2026-05-14 | NORWALK, LESLIE V | Director | Buy | 1,447 | $97.15 | $140576.05 |
| 2026-05-14 | MAHONEY, MICHAEL F | Director | Buy | 1,737 | $97.15 | $168749.55 |
| 2026-05-14 | KIRBY, J SCOTT | Director | Buy | 1,447 | $97.15 | $140576.05 |
| 2026-05-14 | GALLINA, JOHN E | Director | Buy | 1,448 | $97.15 | $140673.20 |
| 2026-05-14 | FINUCANE, ANNE A. | Director | Buy | 1,544 | $97.15 | $149999.60 |
| 2026-05-14 | DECOUDREAUX, ALECIA A | Director | Buy | 1,448 | $97.15 | $140673.20 |
| 2026-05-14 | BROWN, C DAVID II | Director | Buy | 1,544 | $97.15 | $149999.60 |
| 2026-05-14 | BALSER, JEFFREY R. | Director | Buy | 2,058 | $97.15 | $199934.70 |
| 2026-05-14 | AGUIRRE, FERNANDO | Director | Buy | 1,563 | $97.15 | $151845.45 |
| 2026-05-08 | MANDADI, TILAK | EVP, Chief Exp & Tech Officer | Sale | 69,551 | $89.58 | $6.23M |
| 2026-04-01 | SHAH, PREM S | EVP and Group President | Sale | 1,484 | $72.49 | $107575.16 |
| 2026-04-01 | NELSON, STEVEN H | EVP and President, Aetna | Sale | 2,432 | $72.49 | $176295.68 |
| 2026-04-01 | MANDADI, TILAK | EVP, Chief Exp & Tech Officer | Sale | 3,634 | $72.49 | $263428.66 |
| 2026-04-01 | KHICHI, SAMRAT S. | EVP, CPO and General Counsel | Sale | 3,541 | $72.49 | $256687.09 |
| 2026-04-01 | JOYNER, J. DAVID | Director, President, CEO and Chair | Sale | 8,029 | $72.49 | $582022.21 |
| 2026-04-01 | CLARK, JAMES DAVID | SVP, Cont & Chief Acct Officer | Sale | 3,262 | $72.49 | $236462.38 |
| 2026-04-01 | CAPOZZI, HEIDI B | EVP and Chief People Officer | Sale | 1,334 | $72.49 | $96701.66 |
| 2026-03-31 | SHAH, PREM S | EVP and Group President | Buy | 161,676 | $71.82 | $11.61M |
| 2026-03-31 | SHAH, PREM S | EVP and Group President | Buy | 25,062 | $71.82 | $1.80M |
| 2026-03-31 | NEWMAN, BRIAN | EVP, Chief Financial Officer | Buy | 125,748 | $71.82 | $9.03M |
| 2026-03-31 | NEWMAN, BRIAN | EVP, Chief Financial Officer | Buy | 19,493 | $71.82 | $1.40M |
| 2026-03-31 | NELSON, STEVEN H | EVP and President, Aetna | Buy | 143,712 | $71.82 | $10.32M |
| 2026-03-31 | NELSON, STEVEN H | EVP and President, Aetna | Buy | 22,277 | $71.82 | $1.60M |
| 2026-03-31 | MANDADI, TILAK | EVP, Chief Exp & Tech Officer | Buy | 143,712 | $71.82 | $10.32M |
| 2026-03-31 | MANDADI, TILAK | EVP, Chief Exp & Tech Officer | Buy | 22,277 | $71.82 | $1.60M |
| 2026-03-31 | KHICHI, SAMRAT S. | EVP, CPO and General Counsel | Buy | 80,838 | $71.82 | $5.81M |
| 2026-03-31 | KHICHI, SAMRAT S. | EVP, CPO and General Counsel | Buy | 12,531 | $71.82 | $899976.42 |
| 2026-03-31 | JOYNER, J. DAVID | Director, President, CEO and Chair | Buy | 86,326 | $71.82 | $6.20M |
| 2026-03-31 | COMPTON-PHILLIPS, AMY | EVP, Chief Medical Officer | Buy | 35,928 | $71.82 | $2.58M |
| 2026-03-31 | COMPTON-PHILLIPS, AMY | EVP, Chief Medical Officer | Buy | 5,569 | $71.82 | $399965.58 |
| 2026-03-31 | CLARK, JAMES DAVID | SVP, Cont & Chief Acct Officer | Buy | 11,976 | $71.82 | $860116.32 |
| 2026-03-31 | CLARK, JAMES DAVID | SVP, Cont & Chief Acct Officer | Buy | 11,138 | $71.82 | $799931.16 |
| 2026-03-31 | CAPOZZI, HEIDI B | EVP and Chief People Officer | Buy | 64,670 | $71.82 | $4.64M |
| 2026-03-31 | CAPOZZI, HEIDI B | EVP and Chief People Officer | Buy | 10,025 | $71.82 | $719995.50 |
| 2026-03-19 | GALLINA, JOHN E | Director | Buy | 582 | $71.86 | $41822.52 |
| 2026-02-28 | KHICHI, SAMRAT S. | EVP, CPO and General Counsel | Sale | 7,886 | $79.60 | $627725.60 |
| 2026-02-28 | JOYNER, J. DAVID | Director, President and CEO | Sale | 1,944 | $79.90 | $155325.60 |
| 2026-01-01 | SHAH, PREM S | EVP and Group President | Sale | 247 | $80.13 | $19792.11 |
| 2025-12-01 | CLARK, JAMES DAVID | SVP, Cont & Chief Acct Officer | Sale | 220 | $79.10 | $17402.00 |
| 2025-11-30 | MANDADI, TILAK | EVP, Chief Exp & Tech Officer | Sale | 6,575 | $80.36 | $528367.00 |
| 2025-11-30 | FARAH, ROGER N | Director | Sale | 9,748 | $80.36 | $783349.28 |
| 2025-11-30 | CAPOZZI, HEIDI B | EVP and Chief People Officer | Sale | 9,470 | $80.36 | $761009.20 |
| 2025-11-20 | SHULMAN, DOUGLAS H. | Director | Buy | 1,652 | $76.04 | $125618.08 |
| 2025-11-20 | SANSONE, GUY P | Director | Buy | 1,652 | $76.04 | $125618.08 |
| 2025-11-20 | ROBBINS, LARRY | Director | Buy | 2,203 | $76.04 | $167516.12 |
| 2025-11-20 | NORWALK, LESLIE V | Director | Buy | 1,652 | $76.04 | $125618.08 |
| 2025-11-20 | MAHONEY, MICHAEL F | Director | Buy | 2,022 | $76.04 | $153752.88 |
| 2025-11-20 | KIRBY, J SCOTT | Director | Buy | 1,652 | $76.04 | $125618.08 |
| 2025-11-20 | FINUCANE, ANNE A. | Director | Buy | 1,775 | $76.04 | $134971.00 |
| 2025-11-20 | FINUCANE, ANNE A. | Director | Buy | 591 | $76.04 | $44939.64 |
| 2025-11-20 | DECOUDREAUX, ALECIA A | Director | Buy | 1,652 | $76.04 | $125618.08 |
| 2025-11-20 | BROWN, C DAVID II | Director | Buy | 1,775 | $76.04 | $134971.00 |
| 2025-11-20 | BALSER, JEFFREY R. | Director | Buy | 1,775 | $76.04 | $134971.00 |
| 2025-11-20 | AGUIRRE, FERNANDO | Director | Buy | 1,800 | $76.04 | $136872.00 |
| 2025-08-31 | SHAH, PREM S | EVP and Group President | Sale | 6,995 | $73.15 | $511684.25 |
| 2025-08-31 | MANDADI, TILAK | EVP, Chief Exp & Tech Officer | Sale | 12,834 | $73.15 | $938807.10 |
| 2025-08-20 | FINUCANE, ANNE A. | Director | Sale | 7,500 | $71.02 | $532650.00 |
| 2025-06-05 | SANSONE, GUY P | Director | Buy | 1,570 | $63.70 | $100009.00 |
| 2025-05-31 | NEWMAN, BRIAN | EVP, Chief Financial Officer | Buy | 94,786 | — | — |
| 2025-05-31 | NEWMAN, BRIAN | EVP, Chief Financial Officer | Buy | 21,861 | $64.04 | $1.40M |
| 2025-05-31 | COMPTON-PHILLIPS, AMY | EVP, Chief Medical Officer | Buy | 27,081 | — | — |
| 2025-05-31 | COMPTON-PHILLIPS, AMY | EVP, Chief Medical Officer | Buy | 46,845 | $64.04 | $3.00M |
| 2025-05-31 | COMPTON-PHILLIPS, AMY | EVP, Chief Medical Officer | Buy | 6,246 | $64.04 | $399993.84 |
| 2025-05-15 | SHULMAN, DOUGLAS H. | Director | Buy | 2,077 | $60.47 | $125596.19 |
| 2025-05-15 | SANSONE, GUY P | Director | Buy | 2,077 | $60.47 | $125596.19 |
| 2025-05-15 | ROBBINS, LARRY | Director | Buy | 2,770 | $60.47 | $167501.90 |
| 2025-05-15 | NORWALK, LESLIE V | Director | Buy | 2,077 | $60.47 | $125596.19 |
| 2025-05-15 | MAHONEY, MICHAEL F | Director | Buy | 2,543 | $60.47 | $153775.21 |
| 2025-05-15 | MAHONEY, MICHAEL F | Director | Buy | 144 | $60.47 | $8707.68 |
| 2025-05-15 | KIRBY, J SCOTT | Director | Buy | 2,769 | $60.47 | $167441.43 |
| 2025-05-15 | FINUCANE, ANNE A. | Director | Buy | 2,077 | $60.47 | $125596.19 |
| 2025-05-15 | FINUCANE, ANNE A. | Director | Buy | 692 | $60.47 | $41845.24 |
| 2025-05-15 | DECOUDREAUX, ALECIA A | Director | Buy | 2,077 | $60.47 | $125596.19 |
| 2025-05-15 | BROWN, C DAVID II | Director | Buy | 2,232 | $60.47 | $134969.04 |
| 2025-05-15 | BALSER, JEFFREY R. | Director | Buy | 2,232 | $60.47 | $134969.04 |
| 2025-05-15 | AGUIRRE, FERNANDO | Director | Buy | 2,263 | $60.47 | $136843.61 |
| 2025-05-06 | ROBBINS, LARRY | Director | Sale | 150,000 | $66.67 | $10.00M |
| 2025-05-05 | ROBBINS, LARRY | Director | Sale | 1,226,933 | $67.37 | $82.65M |
| 2025-05-05 | ROBBINS, LARRY | Director | Sale | 96,999 | $67.99 | $6.60M |
| 2025-05-02 | ROBBINS, LARRY | Director | Sale | 1,679,736 | $67.39 | $113.19M |
| 2025-05-02 | ROBBINS, LARRY | Director | Sale | 373,776 | $69.66 | $26.04M |
| 2025-05-02 | ROBBINS, LARRY | Director | Sale | 222,556 | $68.38 | $15.22M |
| 2025-04-01 | SHAH, PREM S | EVP and Group President | Buy | 112,289 | $67.98 | $7.63M |
| 2025-04-01 | SHAH, PREM S | EVP and Group President | Buy | 26,478 | $67.98 | $1.80M |
| 2025-04-01 | SHAH, PREM S | EVP and Group President | Sale | 1,308 | $67.98 | $88917.84 |
Frequently asked questions
Are CVS insiders buying or selling?
Over the transactions on record, CVS insiders have been net buyers, with about $623.27M in stock sold across 37 sales, against 61 open-market purchases.
Does insider selling at CVS mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which CVS insiders are selling the most?
Recent selling is concentrated in a few names. ROBBINS, LARRY accounts for the largest share on record, with about $606.44M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.